Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study. (Q44195299)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study. |
scientific article published in November 2002 |
Statements
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study (English)
Ornella Carbonara
Dario Iafusco
Teresa Salvatore
Rosanna D'Ambrosio
Roberto Torella
Domenico Cozzolino
1 November 2002